The future of SGLT2i in HF: Managing patients without T2DM?
This lecture by Prof. Voors was part of a CME accredited symposium: Heart Failure, diabetes & SGLT2i: Time to change practice? held at ESC Heart Failure 2019 in Athens, Greece.
Adriaan Voors is Professor of Cardiology at the University Medical Center Groningen, the Netherlands and he is specialized in heart failure. He has authored more than 500 peer-reviewed papers and several books and chapters.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim/Lilly.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: